Cardiovascular
Antihypertensives, lipid regulators and antiplatelet therapies for long-term chronic care.
Founded in Portugal · 2015
Medicines held to a European standard
Swiss Cure Pharmaceutical develops, manufactures and markets quality medicines trusted by healthcare professionals across Europe and beyond.
2015Founded in Lisbon
20+Markets served
EU-GMPCertified facilities
Who we are
A Portuguese company with a European reach
Swiss Cure Pharmaceutical was established in Lisbon in 2015 with a single conviction: that reliable medicine begins with uncompromising process. What started as a small formulation team has grown into an integrated company spanning development, manufacturing, regulatory affairs and commercial operations.
We work in the space between science and access — building products that meet strict European regulatory expectations while remaining affordable for the health systems that depend on them.
- Full in-house development and formulation
- Regulatory dossiers across EU and export markets
- Pharmacovigilance and post-market surveillance
2015Founded in Lisbon, Portugal
2017First EU-GMP certification granted
2019Expansion into export markets
2022Second production line commissioned
Portfolio
Therapeutic areas
Our portfolio focuses on established, high-need categories where consistent quality matters most.
Anti-infectives
Antibiotics and antifungals produced under dedicated containment and cross-contamination controls.
Neurology & CNS
Treatments supporting neurological and psychiatric care, with strict batch-to-batch consistency.
Gastroenterology
Acid suppression, motility and digestive health products in solid and liquid oral forms.
Dermatology
Topical formulations developed in our semi-solids suite, from corticosteroids to antifungals.
Pain & Inflammation
Analgesic and anti-inflammatory products covering both acute and chronic indications.
Our products
A portfolio built on consistency
A selection from our registered range. These are prescription-only medicines; full product dossiers are available to partners on request.
Film-coated tablets
Heilung
Tofacitinib · 5 mg · 60 tablets
A JAK inhibitor, supplied as film-coated tablets. Prescription only.
Extended-release tablets
Heilung XR
Tofacitinib · 11 mg · 30 tablets
The extended-release presentation of the Heilung line. Not to be crushed or split.
Hard capsules
UltraCure
Itraconazole · 200 mg · 30 capsules
A triazole antifungal in hard gelatin capsules, supplied in vegetarian shells.
Dispersible tablets
SafeCure
Ketorolac tromethamine · 10 mg · 20 tablets
A non-steroidal anti-inflammatory, supplied as dispersible tablets.
Inside Swiss Cure
Where our medicines are made
Development, production, quality control and distribution, under one integrated operation.
Quality & compliance
Nothing leaves without proof
Every batch is traceable from raw material to patient. Our quality system is built around continuous verification, not final inspection.
01
EU-GMP certified
Facilities audited and certified under European Good Manufacturing Practice.
02
ISO 9001 quality system
Documented processes reviewed and improved on a continuous cycle.
03
Full serialisation
Unit-level traceability compliant with the EU Falsified Medicines Directive.
04
Pharmacovigilance
Dedicated safety team monitoring products throughout their market life.
Work with us
Partnerships
We collaborate with distributors, licence holders and healthcare institutions across three models.
Distribution
Territory-exclusive agreements for partners with established pharmacy and hospital channels.
In & out-licensing
Dossier licensing in both directions, with full regulatory support through registration.
Contract manufacturing
Available capacity across solid oral, semi-solid and liquid forms under your brand.
Contact
Let's talk
For partnership enquiries, regulatory documentation or medical information, reach our team directly.
- Headquarters
- Avenida da Liberdade 110
1250-146 Lisbon, Portugal - [email protected]
Thank you for reaching out
Your message has been received. Our team will get back to you within two business days.